{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:31Z","timestamp":1794002851950,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2023-060"],"award-info":[{"award-number":["2023-060"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019-108"],"award-info":[{"award-number":["2019-108"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["223273"],"award-info":[{"award-number":["223273"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n            <jats:italic>Toxoplasma gondii<\/jats:italic> (TG) is a prevalent parasite that establishes lifelong latency after primary infection. TG has been linked to severe mental illness (SMI), potentially through dopamine dysregulation in the brain. There is a bidirectional interaction between dopamine and the hypothalamic-pituitary-adrenal axis, where dopamine may influence cortisol regulation and cortisol may affect dopamine release. We hypothesised that TG would be associated with elevated circulatory cortisol levels, increased severity of psychotic symptoms, and structural brain aberrations in SMI. Our study included 765 patients with SMI (515 with schizophrenia spectrum disorders and 250 with bipolar disorders) and 541 healthy controls (HC). TG immunoglobulin G seropositivity and circulatory cortisol concentrations were measured with immunoassays, and T1-weighted MRI scans were processed using FreeSurfer. Psychotic symptom scores were evaluated using the Positive and Negative Syndrome Scale. In SMI, TG seropositivity was associated with higher cortisol levels (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), but not in HC. Seropositive patients had lower total psychotic symptom scores (<jats:italic>p<\/jats:italic>\u2009=\u20090.006) than seronegative patients, driven by the schizophrenia subgroup (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). This effect was observed for positive, negative, and general psychotic symptom scores, but only for patients with an illness duration of 10 years or more. In an exploratory analysis, TG seropositivity was nominally associated with smaller thalamus, nucleus accumbens, and middle temporal volumes in SMI, and with smaller fusiform, parahippocampal, and pars triangularis volumes in HC. In conclusion, TG exposure in SMI was linked to elevated cortisol levels and reduced psychotic symptom scores, suggesting that its impact on SMI may be more complex and context-dependent than previously assumed.<\/jats:p>","DOI":"10.1038\/s41537-025-00630-0","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:03:13Z","timestamp":1748250193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Toxoplasma gondii associated with psychotic symptom load and cortisol in severe mental illness"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-3383","authenticated-orcid":false,"given":"Dimitrios","family":"Andreou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-1179","authenticated-orcid":false,"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-4809","authenticated-orcid":false,"given":"Kjetil Nordb\u00f8","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-8856","authenticated-orcid":false,"given":"Stener","family":"Nerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-3172","authenticated-orcid":false,"given":"Laura A.","family":"Wortinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Drabl\u00f8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Calkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica B. E. G.","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn Sofie","family":"S\u00e6ther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-3568","authenticated-orcid":false,"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"630_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1574-6976.2011.00305.x","volume":"36","author":"WJ Sullivan Jr.","year":"2012","unstructured":"Sullivan, W. J. Jr. & Jeffers, V. Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol. Rev. 36, 717\u2013733 (2012).","journal-title":"FEMS Microbiol. Rev."},{"key":"630_CR2","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/jpids\/piu077","volume":"3","author":"JB McAuley","year":"2014","unstructured":"McAuley, J. B. Congenital toxoplasmosis. J. Pediatr. Infect. Dis. Soc. 3, S30\u2013S35 (2014).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter, A. M., Heckeroth, A. R. & Weiss, L. M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30, 1217\u20131258 (2000).","journal-title":"Int. J. Parasitol."},{"key":"630_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.12423","volume":"132","author":"AL Sutterland","year":"2015","unstructured":"Sutterland, A. L. et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr. Scand. 132, 161\u2013179 (2015).","journal-title":"Acta Psychiatr. Scand."},{"key":"630_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1176\/appi.prcp.20210041","volume":"4","author":"DG Contopoulos-Ioannidis","year":"2022","unstructured":"Contopoulos-Ioannidis, D. G., Gianniki, M., Ai-Nhi Truong, A. & Montoya, J. G. Toxoplasmosis and schizophrenia: a systematic review and meta-analysis of prevalence and associations and future directions. Psychiatr. Res. Clin. Pract. 4, 48\u201360 (2022).","journal-title":"Psychiatr. Res. Clin. Pract."},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpsychires.2024.05.025","volume":"175","author":"L Yang","year":"2024","unstructured":"Yang, L. et al. Toxoplasma gondii infection positively associated with schizophrenia: Evidences from UK Biobank cohort and case-controlled studies. J. Psychiatr. Res. 175, 243\u2013250 (2024).","journal-title":"J. Psychiatr. Res."},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jad.2016.11.016","volume":"209","author":"J de Barros","year":"2017","unstructured":"de Barros, J. et al. Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J. Affect. Disord. 209, 59\u201365 (2017).","journal-title":"J. Affect. Disord."},{"key":"630_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpsychires.2022.07.013","volume":"153","author":"G Cossu","year":"2022","unstructured":"Cossu, G., Preti, A., Gyppaz, D., Gureje, O. & Carta, M. G. Association between toxoplasmosis and bipolar disorder: a systematic review and meta-analysis. J. Psychiatr. Res. 153, 284\u2013291 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40588-015-0024-0","volume":"2","author":"J Flegr","year":"2015","unstructured":"Flegr, J. Neurological and neuropsychiatric consequences of chronic toxoplasma infection. Curr. Clin. Microbiol. Rep. 2, 163\u2013172 (2015).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1242\/jeb.074153","volume":"216","author":"GA McConkey","year":"2013","unstructured":"McConkey, G. A., Martin, H. L., Bristow, G. C. & Webster, J. P. Toxoplasma gondii infection and behaviour - location, location, location?. J. Exp. Biol. 216, 113\u2013119 (2013).","journal-title":"J. Exp. Biol."},{"key":"630_CR11","doi-asserted-by":"crossref","unstructured":"Sutterland, A. L. et al. Toxoplasma gondii infection and clinical characteristics of patients with schizophrenia: a systematic review and meta-analysis. Schizophr. Bull. Open 1, sgaa042 (2020).","DOI":"10.1093\/schizbullopen\/sgaa042"},{"key":"630_CR12","doi-asserted-by":"crossref","unstructured":"Del Grande, C., Galli, L., Schiavi, E., Dell\u2019Osso, L. & Bruschi, F. Is Toxoplasma gondii a trigger of bipolar disorder? Pathogens 6, 3 (2017).","DOI":"10.3390\/pathogens6010003"},{"key":"630_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1471-4159.2010.06604.x","volume":"113","author":"E Perez-Costas","year":"2010","unstructured":"Perez-Costas, E., Melendez-Ferro, M. & Roberts, R. C. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J. Neurochem. 113, 287\u2013302 (2010).","journal-title":"J. Neurochem."},{"key":"630_CR14","first-page":"47","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch, R. et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front. Psychiatry 5, 47 (2014).","journal-title":"Front. Psychiatry"},{"key":"630_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 35, 549\u2013562 (2009).","journal-title":"Schizophr. Bull."},{"key":"630_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2017.16","volume":"22","author":"AH Ashok","year":"2017","unstructured":"Ashok, A. H. et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol. Psychiatry 22, 666\u2013679 (2017).","journal-title":"Mol. Psychiatry"},{"key":"630_CR17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","volume":"381","author":"N Craddock","year":"2013","unstructured":"Craddock, N. & Sklar, P. Genetics of bipolar disorder. Lancet 381, 1654\u20131662 (2013).","journal-title":"Lancet"},{"key":"630_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","volume":"74","author":"S Jauhar","year":"2017","unstructured":"Jauhar, S. et al. A Test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 74, 1206\u20131213 (2017).","journal-title":"JAMA Psychiatry"},{"key":"630_CR19","first-page":"956","volume":"4","author":"NR Karcher","year":"2019","unstructured":"Karcher, N. R., Rogers, B. P. & Woodward, N. D. Functional connectivity of the striatum in schizophrenia and psychotic bipolar disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimag. 4, 956\u2013965 (2019).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimag."},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","volume":"28","author":"AE Whitton","year":"2015","unstructured":"Whitton, A. E., Treadway, M. T. & Pizzagalli, D. A. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr. Opin. Psychiatry 28, 7\u201312 (2015).","journal-title":"Curr. Opin. Psychiatry"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2011.10.009","volume":"71","author":"R Mizrahi","year":"2012","unstructured":"Mizrahi, R. et al. Increased stress-induced dopamine release in psychosis. Biol. Psychiatry 71, 561\u2013567 (2012).","journal-title":"Biol. Psychiatry"},{"key":"630_CR22","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1007\/s12035-022-02976-3","volume":"59","author":"A de Bartolomeis","year":"2022","unstructured":"de Bartolomeis, A. et al. Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a systematic review. Mol. Neurobiol. 59, 6460\u20136501 (2022).","journal-title":"Mol. Neurobiol."},{"key":"630_CR23","unstructured":"Thau, L., Gandhi, J. & Sharma, S. Physiology, cortisol. In StatPearls (2025)."},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.psyneuen.2014.07.013","volume":"49","author":"L Girshkin","year":"2014","unstructured":"Girshkin, L., Matheson, S. L., Shepherd, A. M. & Green, M. J. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 49, 187\u2013206 (2014).","journal-title":"Psychoneuroendocrinology"},{"key":"630_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.psyneuen.2019.03.014","volume":"104","author":"DB Hubbard","year":"2019","unstructured":"Hubbard, D. B. & Miller, B. J. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology 104, 269\u2013275 (2019).","journal-title":"Psychoneuroendocrinology"},{"key":"630_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neubiorev.2016.05.027","volume":"68","author":"M Berger","year":"2016","unstructured":"Berger, M. et al. Cortisol awakening response in patients with psychosis: systematic review and meta-analysis. Neurosci. Biobehav Rev. 68, 157\u2013166 (2016).","journal-title":"Neurosci. Biobehav Rev."},{"key":"630_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neubiorev.2016.12.013","volume":"73","author":"M Pruessner","year":"2017","unstructured":"Pruessner, M., Cullen, A. E., Aas, M. & Walker, E. F. The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci. Biobehav. Rev. 73, 191\u2013218 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"630_CR28","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","volume":"24","author":"JC Pruessner","year":"2004","unstructured":"Pruessner, J. C., Champagne, F., Meaney, M. J. & Dagher, A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci. 24, 2825\u20132831 (2004).","journal-title":"J. Neurosci."},{"key":"630_CR29","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1038\/sj.npp.1301373","volume":"32","author":"GS Wand","year":"2007","unstructured":"Wand, G. S. et al. Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology 32, 2310\u20132320 (2007).","journal-title":"Neuropsychopharmacology"},{"key":"630_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.psyneuen.2016.11.034","volume":"76","author":"D Payer","year":"2017","unstructured":"Payer, D. et al. Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology 76, 192\u2013196 (2017).","journal-title":"Psychoneuroendocrinology"},{"key":"630_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijppaw.2021.11.007","volume":"17","author":"ZM Laubach","year":"2022","unstructured":"Laubach, Z. M. et al. Associations between Toxoplasma gondii infection and steroid hormone levels in spotted hyenas. Int. J. Parasitol. Parasites Wildl. 17, 53\u201359 (2022).","journal-title":"Int. J. Parasitol. Parasites Wildl."},{"key":"630_CR32","unstructured":"Shirbazou, S., Abasian, L. & Talebi Meymand, F. Effects of Toxoplasma gondii infection on plasma testosterone and cortisol level and stress index on patients referred to Sina hospital, Tehran. Jundishapur J. Microbiol. 4, 167\u2013174 (2011)."},{"key":"630_CR33","doi-asserted-by":"crossref","unstructured":"El-Gebaly, N. S. M. et al. Insights into the interplay of latent toxoplasmosis, testosterone, cortisol and oxidative stress in screened schizophrenic patients in Egypt. Parasitologists United J. 19, e0297362 (2019).","DOI":"10.21608\/puj.2019.11819.1040"},{"key":"630_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/15622975.2011.573809","volume":"13","author":"J Horacek","year":"2012","unstructured":"Horacek, J. et al. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J. Biol. Psychiatry 13, 501\u2013509 (2012).","journal-title":"World J. Biol. Psychiatry"},{"key":"630_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.4","volume":"7","author":"CF van Kesteren","year":"2017","unstructured":"van Kesteren, C. F. et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl. Psychiatry 7, e1075 (2017).","journal-title":"Transl. Psychiatry"},{"key":"630_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/157339510791823673","volume":"6","author":"N Muller","year":"2010","unstructured":"Muller, N. & Schwarz, M. J. Immune system and schizophrenia. Curr. Immunol. Rev. 6, 213\u2013220 (2010).","journal-title":"Curr. Immunol. Rev."},{"key":"630_CR37","doi-asserted-by":"crossref","unstructured":"Rosenblat, J. D. & McIntyre, R. S. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain. Sci. 7, 144 (2017).","DOI":"10.3390\/brainsci7110144"},{"key":"630_CR38","doi-asserted-by":"crossref","unstructured":"Patel, J. P. & Frey, B. N. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015, 708306 (2015).","DOI":"10.1155\/2015\/708306"},{"key":"630_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fpsyt.2017.00083","volume":"8","author":"S Najjar","year":"2017","unstructured":"Najjar, S. et al. Neurovascular unit dysfunction and blood-brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence. Front. Psychiatry 8, 83 (2017).","journal-title":"Front. Psychiatry"},{"key":"630_CR40","unstructured":"First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. Structured clinical interview for DSM-IV axis I disorders (SCIDI), clinician version, administration booklet. (American Psychiatric Association Publishing, 2012)."},{"key":"630_CR41","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.1994.03520220043029","volume":"272","author":"RL Spitzer","year":"1994","unstructured":"Spitzer, R. L. et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272, 1749\u20131756 (1994).","journal-title":"JAMA"},{"key":"630_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/jech.2004.023531","volume":"60","author":"B Galobardes","year":"2006","unstructured":"Galobardes, B., Shaw, M., Lawlor, D. A., Lynch, J. W. & Davey Smith, G. Indicators of socioeconomic position (part 1). J. Epidemiol. Commun. Health 60, 7\u201312 (2006).","journal-title":"J. Epidemiol. Commun. Health"},{"key":"630_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","volume":"56","author":"MJ Bohn","year":"1995","unstructured":"Bohn, M. J., Babor, T. F. & Kranzler, H. R. The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings. J. Stud. Alcohol. 56, 423\u2013432 (1995).","journal-title":"J. Stud. Alcohol."},{"key":"630_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000081413","volume":"11","author":"AH Berman","year":"2005","unstructured":"Berman, A. H., Bergman, H., Palmstierna, T. & Schlyter, F. Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur. Addict. Res. 11, 22\u201331 (2005).","journal-title":"Eur. Addict. Res."},{"key":"630_CR45","unstructured":"Wechsler, D. Wechsler abbreviated scale of intelligence (WASI). Norwegian manual supplement. Stockholm, Sweden: Pearson Assessment (2007)."},{"key":"630_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"630_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429\u2013435 (1978).","journal-title":"Br. J. Psychiatry"},{"key":"630_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1017\/S0033291700035558","volume":"26","author":"AJ Rush","year":"1996","unstructured":"Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B. & Trivedi, M. H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med 26, 477\u2013486 (1996).","journal-title":"Psychol. Med"},{"key":"630_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","volume":"67","author":"NC Andreasen","year":"2010","unstructured":"Andreasen, N. C., Pressler, M., Nopoulos, P., Miller, D. & Ho, B. C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 67, 255\u2013262 (2010).","journal-title":"Biol. Psychiatry"},{"key":"630_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55887-9","volume":"14","author":"D Andreou","year":"2024","unstructured":"Andreou, D. et al. Toxoplasma gondii infection associated with inflammasome activation and neuronal injury. Sci. Rep. 14, 5327 (2024).","journal-title":"Sci. Rep."},{"key":"630_CR51","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1086\/319221","volume":"32","author":"RH Yolken","year":"2001","unstructured":"Yolken, R. H. et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin. Infect. Dis. 32, 842\u2013844 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"630_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105721","volume":"140","author":"G Hjell","year":"2022","unstructured":"Hjell, G. et al. Interleukin-18 signaling system links to agitation in severe mental disorders. Psychoneuroendocrinology 140, 105721 (2022).","journal-title":"Psychoneuroendocrinology"},{"key":"630_CR53","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl, B. FreeSurfer. Neuroimage 62, 774\u2013781 (2012).","journal-title":"Neuroimage"},{"key":"630_CR54","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968\u2013980 (2006).","journal-title":"Neuroimage"},{"key":"630_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fnins.2015.00379","volume":"9","author":"CS McCarthy","year":"2015","unstructured":"McCarthy, C. S. et al. A comparison of FreeSurfer-generated data with and without manual intervention. Front. Neurosci. 9, 379 (2015).","journal-title":"Front. Neurosci."},{"key":"630_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"630_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03198-y","volume":"14","author":"D Andreou","year":"2024","unstructured":"Andreou, D. et al. Increased Herpes simplex virus 1, Toxoplasma gondii and Cytomegalovirus antibody concentrations in severe mental illness. Transl. Psychiatry 14, 498 (2024).","journal-title":"Transl. Psychiatry"},{"key":"630_CR58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00213-009-1613-5","volume":"206","author":"X Belda","year":"2009","unstructured":"Belda, X. & Armario, A. Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis. Psychopharmacology 206, 355\u2013365 (2009).","journal-title":"Psychopharmacology"},{"key":"630_CR59","first-page":"667","volume":"55","author":"A Czyrak","year":"2003","unstructured":"Czyrak, A., Mackowiak, M., Chocyk, A., Fijal, K. & Wedzony, K. Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol. J. Pharm. 55, 667\u2013674 (2003).","journal-title":"Pol. J. Pharm."},{"key":"630_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.17219\/acem\/61435","volume":"26","author":"AJ Fuglewicz","year":"2017","unstructured":"Fuglewicz, A. J., Piotrowski, P. & Stodolak, A. Relationship between toxoplasmosis and schizophrenia: a review. Adv. Clin. Exp. Med. 26, 1031\u20131036 (2017).","journal-title":"Adv. Clin. Exp. Med."},{"key":"630_CR61","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1093\/schbul\/sbx023.077","volume":"43","author":"D Cobia","year":"2017","unstructured":"Cobia, D. et al. SA79. Toxoplasma Gondii affects posterior association cortex and related functions in healthy, but not schizophrenia, individuals. Schizophr. Bull. 43, S141\u2013S141 (2017).","journal-title":"Schizophr. Bull."},{"key":"630_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03014-w","volume":"21","author":"TL Baker","year":"2024","unstructured":"Baker, T. L. et al. A pre-existing Toxoplasma gondii infection exacerbates the pathophysiological response and extent of brain damage after traumatic brain injury in mice. J. Neuroinflamm. 21, 14 (2024).","journal-title":"J. Neuroinflamm."},{"key":"630_CR63","doi-asserted-by":"publisher","first-page":"24796","DOI":"10.1073\/pnas.1915778116","volume":"116","author":"CA Schneider","year":"2019","unstructured":"Schneider, C. A. et al. Imaging the dynamic recruitment of monocytes to the blood-brain barrier and specific brain regions during Toxoplasma gondii infection. Proc. Natl. Acad. Sci. USA 116, 24796\u201324807 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"630_CR64","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760200007","volume":"115","author":"Y Meurer","year":"2020","unstructured":"Meurer, Y. et al. Toxoplasma gondii infection damages the perineuronal nets in a murine model. Mem. Inst. Oswaldo Cruz 115, e200007 (2020).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"630_CR65","doi-asserted-by":"crossref","unstructured":"Watts, E. et al. Novel approaches reveal that toxoplasma gondii bradyzoites within tissue cysts are dynamic and replicating entities in vivo. mBio 6, e01155\u201301115 (2015).","DOI":"10.1128\/mBio.01155-15"},{"key":"630_CR66","doi-asserted-by":"crossref","unstructured":"Larsson, C. A., Gullberg, B., Rastam, L. & Lindblad, U. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocr. Disord. 9, 16 (2009).","DOI":"10.1186\/1472-6823-9-16"},{"key":"630_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.maturitas.2022.10.006","volume":"168","author":"MI Stamou","year":"2023","unstructured":"Stamou, M. I., Colling, C. & Dichtel, L. E. Adrenal aging and its effects on the stress response and immunosenescence. Maturitas 168, 13\u201319 (2023).","journal-title":"Maturitas"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00630-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00630-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00630-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:02:26Z","timestamp":1748253746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00630-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00630-0","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.A.A. is a consultant to CorTechs and Precision Health and received speaker\u2019s honoraria from Janssen, Lundbeck, and Sunovion. I.A. received speaker\u2019s honoraria from Lundbeck. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}